Responsible Care
10-aug-2010
Bayer verhoogt omzet en winst in tweede kwartaal 2010
Sales grow by 14.6 percent to EUR 9,179 million
EBITDA before special items up 8.6 percent to EUR 1,917 million
Core earnings per share increase by 9.5 percent to EUR 1.15
Investing in the future: research and development expenses in 2010 to reach a new high of approximately EUR 3.1 billion
Bayer verhoogt omzet en winst in tweede kwartaal 2010
EBITDA before special items up 8.6 percent to EUR 1,917 million
Core earnings per share increase by 9.5 percent to EUR 1.15
Investing in the future: research and development expenses in 2010 to reach a new high of approximately EUR 3.1 billion
·
Group outlook confirmed for 2010
Video
Publicaties
Externe links
Kalender